ipscell.com
Doudna most deserving of CRISPR Cas9 patent, says poll - The Niche
Jennifer Doudna is leading by a decisive margin in a pollasking who deserves the patent for use of CRISPR-Cas9 as a tool.
Professor Paul Knoepfler, Ph.D.
